Q4118 HCPCS Level II code: Matristem micromatrix, 1 mg

Q4118 is the HCPCS code for “Matristem micromatrix, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

Q4118

Matristem micromatrix, 1 mg

Short description: Matristem micromatrix

HCPCS · United States

Medicare details

The indicators CMS publishes with Q4118 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Physician fee schedule – Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion)
Type of service
Medical care
BETOS category
Other drugs
Added
Jan 1, 2011

Where Q4118 sits

  1. 1Q codesTemporary codes
  2. 2Active code Q4118Matristem micromatrix, 1 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code Q4118 mean?

Q4118 is the HCPCS code for “Matristem micromatrix, 1 mg” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover Q4118?

CMS lists Q4118’s Medicare coverage as “Carrier judgment” and its pricing as “Physician fee schedule – Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.